pSivida is independently developing a product to treat uveitis affecting the posterior segment of the eye (posterior uveitis).
In addition, the company has partnered with Pfizer for the development of a product to treat glaucoma and ocular hypertension.
Currently, pSivida is focused on the treatment of chronic diseases of the back of the eye utilizing its core technology systems, Durasert and BioSilicon.